179 related articles for article (PubMed ID: 31500935)
1. Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience.
Chatzikonstantinou G; Zamboglou N; Baltas D; Ferentinos K; Bon D; Tselis N
Brachytherapy; 2019; 18(6):829-834. PubMed ID: 31500935
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
Tselis N; Ferentinos K; Kolotas C; Schirren J; Baltas D; Antonakakis A; Ackermann H; Zamboglou N
J Thorac Oncol; 2011 Mar; 6(3):545-52. PubMed ID: 21258257
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study.
Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Zamboglou N
Eur Radiol; 2013 Aug; 23(8):2264-70. PubMed ID: 23515917
[TBL] [Abstract][Full Text] [Related]
5. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique.
Ricke J; Wust P; Wieners G; Hengst S; Pech M; Lopez Hänninen E; Felix R
Chest; 2005 Jun; 127(6):2237-42. PubMed ID: 15947343
[TBL] [Abstract][Full Text] [Related]
6. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
7. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
8. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated accelerated computed tomography-guided interstitial high-dose-rate brachytherapy for liver malignancies.
Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Chung TL; Zamboglou N
Brachytherapy; 2012; 11(6):507-14. PubMed ID: 22571828
[TBL] [Abstract][Full Text] [Related]
10. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
11. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
12. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
13. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
14. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
[TBL] [Abstract][Full Text] [Related]
15. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
[TBL] [Abstract][Full Text] [Related]
16. CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.
Wang ZM; Lu J; Liu T; Chen KM; Huang G; Liu FJ
Lung Cancer; 2011 Nov; 74(2):253-7. PubMed ID: 21513997
[TBL] [Abstract][Full Text] [Related]
17. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.
Yoon SM; Suh R; Abtin F; Moghanaki D; Genshaft S; Kamrava M; Drakaki A; Liu S; Venkat P; Lee A; Chang AJ
Radiat Oncol; 2021 Jun; 16(1):99. PubMed ID: 34098977
[TBL] [Abstract][Full Text] [Related]
18. Interstitial single fraction brachytherapy for malignant pulmonary tumours.
Rashid A; Pinkawa M; Haddad H; Hermani H; Temming S; Schäfer A; Bischoff P; Kovács A
Strahlenther Onkol; 2021 May; 197(5):416-422. PubMed ID: 33725134
[TBL] [Abstract][Full Text] [Related]
19. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
20. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
